QHP CAPITAL, L.P.

Thesis

QHP Capital, L.P. is a private equity firm focused on control-oriented buyouts and recapitalizations of middle-market companies in the healthcare sector, specifically tech-enabled life sciences and pharmaceutical services. They target businesses aiming to reduce care costs, address unmet medical needs, improve clinical efficiency, or enhance patient quality of life, with an enterprise value between $50 million and $500 million. The firm operates in North America and Europe, sourcing deals through thematic research in specialized sub-sectors. QHP Capital utilizes two NovaQuest-branded private equity funds, with Fund I at $275 million and Fund II at $500 million. Their AUM was reported as $4,568,233,295 as of March 30, 2026. A key differentiator is their internal value-creation team of operating professionals and a roster of strategic advisors with deep industry experience, focusing on post-close transformation. The firm was formed in 2021, with predecessors operating since 2010. They have a concentrated portfolio of approximately 10 platform investments since 2018. Their headquarters are in Raleigh, North Carolina, and they accept inquiries via a website form.